Skip to main content
SpringerLink
Log in

Polymyosites et dermatomyosites en urgence

  • Chapter
Maladies rares en médecine d’urgence

Part of the book series: Références en médecine d’urgence. Collection de la SFMU ((REFERMED))

  • 1156 Accesses

Résumé

C’est à Wagner dès 1863 que revient la première description clinique précise des polymyosites (PM) et des dermatomyosites (DM). De fait, il a rapporté les observations de deux patients présentant un tableau aigu de maladie « dégénérative » des muscles avec inflammation et œdème, responsable d’une impotence fonctionnelle sévère.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Cherin P, Marie I (2005) Les nouveaux critères diagnostiques et d’évaluation des polymyosites et dermatomyosites. Rev Med Interne 26: 361–7

    Article  PubMed  CAS  Google Scholar 

  2. Marie I (2011) Therapy of polymyositis and dermatomyositis. Presse Med 40: e257–70

    Article  PubMed  Google Scholar 

  3. Marie I, Mouthon L (2011) Therapy of polymyositis and dermatomyositis. Autoimmun Rev 11: 6–13

    Article  PubMed  CAS  Google Scholar 

  4. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292: 403–7

    Article  PubMed  CAS  Google Scholar 

  5. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292: 344–7

    Article  PubMed  CAS  Google Scholar 

  6. Marie I, Hachulla E, Hatron PY et al. (2001) Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 28: 2230–7

    PubMed  CAS  Google Scholar 

  7. Cherin P, Herson S, Wechsler B et al. (1991) Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Am J Med 91: 162–8

    Article  PubMed  CAS  Google Scholar 

  8. Marie I, Hatron PY, Dominique S et al. (2012) Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum 41: 890–9

    Article  PubMed  CAS  Google Scholar 

  9. Marie I, Josse S, Decaux O et al. (2012) Comparison of long-term outcome between anti-Jo1-and anti-PL7/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11: 739–45

    Article  PubMed  CAS  Google Scholar 

  10. Marie I, Hatron PY, Hachulla E et al. (1998) Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 25: 1336–43

    PubMed  CAS  Google Scholar 

  11. Marie I, Ménard JF, Hachulla E et al. (2011) Infectious complications in polymyositis and dermatomyositis: a series of 279 patients. Semin Arthritis Rheum 41: 48–60

    Article  PubMed  Google Scholar 

  12. Marie I, Hatron PY, Dominique S et al. (2011) Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 63: 3439–47

    Article  PubMed  CAS  Google Scholar 

  13. Marie I (2012) Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 14: 275–85

    Article  PubMed  CAS  Google Scholar 

  14. Marie I, Hachulla E, Levesque H et al. (1999) Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol 26: 2706–9

    PubMed  CAS  Google Scholar 

  15. Marie I, Menard JF, Hatron PY et al. (2010) Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res (Hoboken) 62: 1748–55

    Article  CAS  Google Scholar 

  16. Marie I, Kerleau JM, Ducrotte P et al. (2001) Intravenous immunoglobulins and octreotide as treatment of intestinal pseudo-obstruction revealing a recurrence of polymyositis. Rheumatology (Oxford) 40: 1072–3

    Article  CAS  Google Scholar 

  17. Lundberg IE (2006) The heart in dermatomyositis and polymyositis. Rheumatology (Oxford) 45(Suppl 4): 18–21

    Google Scholar 

  18. Skouri HN, Dec GW, Friedrich MG et al. (2006) Noninvasive imaging in myocarditis. J Am Coll Cardiol 48: 2085–93

    Article  PubMed  Google Scholar 

  19. Buchbinder R, Jolley D, Wyatt M (2001) Population based intervention to change back pain beliefs and disability: three part evaluation. Br Med J 322: 1516–20

    Article  CAS  Google Scholar 

  20. Hill CL, Zhang Y, Sigurgeirsson B et al. (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357: 96–100

    Article  PubMed  CAS  Google Scholar 

  21. Sigurgeirsson B, Lindelöf B, Edhag O et al. (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326: 363–7

    Article  PubMed  CAS  Google Scholar 

  22. Marie I, Hatron PY, Levesque H et al. (1999) Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) 78: 139–47

    Article  CAS  Google Scholar 

  23. Marie I, Guillevin L, Menard JF et al. (2012) Hematological malignancy associated with polymyositis and dermatomyositis. Autoimmun Rev 11: 615–20

    Article  PubMed  CAS  Google Scholar 

  24. Benveniste O, Drouot L, Jouen F et al. (2011) Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum 63: 1961–71

    Article  PubMed  CAS  Google Scholar 

  25. Trallero-Araguás E, Rodrigo-Pendás JÁ, Selva-O’Callaghan A et al. (2012) Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum 64: 523–32

    Article  PubMed  Google Scholar 

  26. Marie I, Dominique S, Janvresse A et al. (2012) Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome. Respir Med 106: 581–7

    Article  PubMed  CAS  Google Scholar 

  27. Marie I, Guegan-Massardier E, Levesque H (2011) Progressive multifocal leukoencephalopathy in refractory polymyositis treated with rituximab. Eur J Intern Med 22: el3–4

    Article  Google Scholar 

  28. Marie I, Heliot P, Roussel F et al. (2005) Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab. Rheumatology (Oxford) 44: 1201–2

    Article  CAS  Google Scholar 

  29. Miller FW, Leitman SF, Cronin ME et al. (1992) Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 326: 1380–4

    Article  PubMed  CAS  Google Scholar 

  30. Harris-Love MO (2005) Safety and efficacy of submaximal eccentric strength training for a subject with polymyositis. Arthritis Rheum 53: 471–4

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de médecine interne, CHU de Rouen, 76031, Rouen Cedex, France

    I. Marie

Authors
  1. I. Marie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Marie .

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Paris

About this chapter

Cite this chapter

Marie, I. (2013). Polymyosites et dermatomyosites en urgence. In: Maladies rares en médecine d’urgence. Références en médecine d’urgence. Collection de la SFMU. Springer, Paris. https://doi.org/10.1007/978-2-8178-0350-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0350-0_22

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0349-4

  • Online ISBN: 978-2-8178-0350-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation